McDonnell W M, Gilsdorf J R, Kent J B, Sheagren J N
Department of Pediatrics, Medical School, University of Michigan, Ann Arbor 48109-0244.
J Clin Microbiol. 1988 Jun;26(6):1202-6. doi: 10.1128/jcm.26.6.1202-1206.1988.
To identify adults who may be at risk for Haemophilus influenzae type b disease by virtue of low levels of antibody against the H. influenzae b capsule and who may thus benefit from receiving H. influenzae b vaccine, we correlated serum anticapsular antibody levels of 388 adult patients with 26 health-related variables, including 3 personal characteristics, 10 laboratory values, 4 drug use categories, and 8 disease categories. Steroid use was consistently associated with low levels of anticapsular antibody; associations were also found between low antibody levels and both non-Caucasian race and increasing age. However, less than 4% of the antibody variability could be attributed to these factors, and they were not predictive of low antibody levels. Thus, although H. influenzae b infections are seen in adults with predisposing medical conditions, on the basis of the present findings, use of the H. influenzae b vaccine in adults cannot be recommended.
为了确定那些可能因抗b型流感嗜血杆菌荚膜抗体水平低而有患b型流感嗜血杆菌病风险、从而可能从接种b型流感嗜血杆菌疫苗中受益的成年人,我们将388名成年患者的血清抗荚膜抗体水平与26个与健康相关的变量进行了关联分析,这些变量包括3个人口学特征、10项实验室指标、4类药物使用情况以及8类疾病。使用类固醇药物始终与抗荚膜抗体水平低相关;在抗体水平低与非白种人种族以及年龄增长之间也发现了关联。然而,这些因素只能解释不到4%的抗体变异性,并且它们并不能预测低抗体水平。因此,尽管在有易感基础疾病的成年人中可见b型流感嗜血杆菌感染,但基于目前的研究结果,不建议在成年人中使用b型流感嗜血杆菌疫苗。